首页|灌注球囊在动静脉瘘狭窄中的临床前可行性研究

灌注球囊在动静脉瘘狭窄中的临床前可行性研究

扫码查看
目前,每年全国都有大量的终末期肾病患者接受维持性血液透析,自体动静脉瘘是其首选的血液通路之一,长期反复的透析会造成部分患者不同程度的透析通路的狭窄.尽管有一些解决方案被用于临床实践中,但这些方案存在效果不佳或者价格昂贵的缺点,开发一种具有较低价格并临床收益良好的器械刻不容缓.该文章通过设计一种新型灌注球囊,结合抗增殖药物紫杉醇注射液,通过体外模拟实验,初步验证了该新型设备存在临床可行性,为后续的动物体内验证以及未来的临床实验提供了有效的理论支撑.
Preclinical Feasibility Study of Perfusion Balloon in Arteriovenous Fistulas Stenosis
There are a large number of patients with end-stage renal disease receiving maintenance hemodialysis in China every year,autogenous arteriovenous fistula is one of the preferred blood access.Long-term repeated dialysis will cause varying degrees of dialysis access stenosis in some patients.Although some methods are used in clinical practice,these programs have the disadvantages of poor effect or high price,so it is urgent to develop a device with a lower price and good clinical benefits.In this paper,a new perfusion balloon was designed,combined with anti-proliferative agents,like paclitaxel injection,and the clinical feasibility of the new device was preliminarily verified through in vitro simulation experiments,which provided effective theoretical support for subsequent animal validation and future clinical trials.

perfusion balloonautogenous arteriovenous fistulahemodialysispaclitaxel

邢智凯、范亚倩、查城

展开 >

上海微创心脉医疗科技(集团)股份有限公司 (上海 201318)

灌注球囊 自体动静脉瘘 血液透析 紫杉醇

2024

中国医疗器械信息
中国医疗器械行业协会

中国医疗器械信息

影响因子:0.375
ISSN:1006-6586
年,卷(期):2024.30(15)